DK0630248T3 - Anvendelse af estriol til fremstilling af et transdermalt terapeutisk system til behandling af klimakteriel osteoporosis - Google Patents

Anvendelse af estriol til fremstilling af et transdermalt terapeutisk system til behandling af klimakteriel osteoporosis

Info

Publication number
DK0630248T3
DK0630248T3 DK93920566T DK93920566T DK0630248T3 DK 0630248 T3 DK0630248 T3 DK 0630248T3 DK 93920566 T DK93920566 T DK 93920566T DK 93920566 T DK93920566 T DK 93920566T DK 0630248 T3 DK0630248 T3 DK 0630248T3
Authority
DK
Denmark
Prior art keywords
estriol
treatment
pct
preparation
therapeutic system
Prior art date
Application number
DK93920566T
Other languages
English (en)
Inventor
Walter Elger
Birgitt Schneider
Michael Oettel
Michael Ernst
Bler Doris H
Michael Dittgen
Original Assignee
Entec
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Entec filed Critical Entec
Application granted granted Critical
Publication of DK0630248T3 publication Critical patent/DK0630248T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7084—Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK93920566T 1992-03-21 1993-03-18 Anvendelse af estriol til fremstilling af et transdermalt terapeutisk system til behandling af klimakteriel osteoporosis DK0630248T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4209295 1992-03-21
PCT/EP1993/000636 WO1993018774A1 (de) 1992-03-21 1993-03-18 Verwendung von östriol zur behandlung von klimakterischer osteoporose

Publications (1)

Publication Number Publication Date
DK0630248T3 true DK0630248T3 (da) 1999-06-23

Family

ID=6454737

Family Applications (1)

Application Number Title Priority Date Filing Date
DK93920566T DK0630248T3 (da) 1992-03-21 1993-03-18 Anvendelse af estriol til fremstilling af et transdermalt terapeutisk system til behandling af klimakteriel osteoporosis

Country Status (12)

Country Link
US (1) US5614213A (da)
EP (1) EP0630248B1 (da)
JP (1) JPH07504672A (da)
AT (1) ATE172118T1 (da)
AU (1) AU665997B2 (da)
CA (1) CA2131822C (da)
DE (1) DE59309063D1 (da)
DK (1) DK0630248T3 (da)
ES (1) ES2123666T3 (da)
HU (1) HU218290B (da)
RU (1) RU2119337C1 (da)
WO (1) WO1993018774A1 (da)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19635883A1 (de) * 1996-09-04 1998-03-05 Lohmann Therapie Syst Lts Transdermales therapeutisches System mit einer Östriol enthaltenden Wirkstoffkombination
DE19918644A1 (de) * 1999-04-16 2000-10-26 Jenapharm Gmbh Pharmazeutische Zusammensetzungen zur lokalen, intradermalen Applikation von Estrogenen
DE102004023984A1 (de) * 2004-05-14 2005-12-08 Hf Arzneimittelforschung Gmbh Filmförmiges, oral zu verabreichendes Arzneimittel, enthaltend Estriol
KR20180121352A (ko) 2017-04-28 2018-11-07 닛토덴코 가부시키가이샤 경피 흡수형 제제

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3510555A1 (de) * 1985-03-21 1986-09-25 Schering AG, 1000 Berlin und 4709 Bergkamen Estriolester
US5108995A (en) * 1987-09-24 1992-04-28 Jencap Research Ltd. Hormone preparation and method
JP3238389B2 (ja) * 1988-10-27 2001-12-10 シエーリング アクチエンゲゼルシヤフト ゲストデン含有の経皮適用のための薬剤
DE3910578A1 (de) * 1989-03-29 1990-10-04 Schering Ag Mittel zur transdermalen applikation enthaltend gestoden
US5116828A (en) * 1989-10-26 1992-05-26 Nippon Zoki Pharmaceutical Co., Ltd. Pharmaceutical composition for treatment of osteoporosis
DK0573604T3 (da) * 1991-02-26 1995-05-29 Procter & Gamble Pharma Fremgangsmåde til behandling af osteoporosis

Also Published As

Publication number Publication date
CA2131822C (en) 2002-12-17
EP0630248A1 (de) 1994-12-28
HU9402698D0 (en) 1994-11-28
ATE172118T1 (de) 1998-10-15
HUT68213A (en) 1995-06-28
ES2123666T3 (es) 1999-01-16
EP0630248B1 (de) 1998-10-14
US5614213A (en) 1997-03-25
DE59309063D1 (de) 1998-11-19
JPH07504672A (ja) 1995-05-25
AU3750093A (en) 1993-10-21
WO1993018774A1 (de) 1993-09-30
HU218290B (en) 2000-07-28
CA2131822A1 (en) 1993-09-22
RU2119337C1 (ru) 1998-09-27
RU94045856A (ru) 1996-08-20
AU665997B2 (en) 1996-01-25

Similar Documents

Publication Publication Date Title
BR9206632A (pt) Sistema de penetração na pele melhorado para melhorada liberação tópica de drogas
NO962162L (no) Dipeptider som bevirker frigjöring av veksthormon
ATE261244T1 (de) Pharmazeutische zusammensetzungen zur vorbeugung und behandlung der ulzerativen kolitis
MY111188A (en) Improvements in or relating to benzothiophenes.
MY129175A (en) Sertraline salts and sustained-release dosage forms of sertraline
BG104727A (en) Pharmaceutical composition of topiramate
ES2136723T3 (es) Utilizacion de n-aril-metilen-etilen-diamino-triacetatos, n-aril-metilen-imino-diacetatos o n,n'-diaril-metilen-etilen-diamino-acetatos contra el estres oxidante.
ES2191475T3 (es) Conjugados de prostaglandina para el tratamiento o prevencion de enfermedades oseas.
DE59401401D1 (de) Pharmazeutische formulierung zur behandlung der nicotinabhängigkeit
DE69825603D1 (de) 2,3,5-trisubstituierte pyridine als inhibitoren von cyclooxygenase-2
ATE171873T1 (de) Antiglucocorticoidsteroide zur behandlung von angststörungen
DE69535131D1 (de) Pharmazeutische zusammensetzungen zur vorbeugung und behandlung von störungen des zentralnervensystems
WO2004058235A3 (en) Method of increasing bioavailability of alendronate or other bis-phosphonate by predose administration of vitamin d derivative
DK0630248T3 (da) Anvendelse af estriol til fremstilling af et transdermalt terapeutisk system til behandling af klimakteriel osteoporosis
SE9303853L (sv) Användning av en inositoltrisfosfatester för beredning av läkemedel
NO975140D0 (no) Transdermalt terapeutisk system (TTS) for administrasjon av testosteron
DK0996435T3 (da) Aminosyrederivater anvendelige til behandling af slagtilfælde
DK0762883T3 (da) Pyridylbisphosphonater til anvendelse som terapeutisk middel
DK0665830T3 (da) Tilidin-dihydrogenorthophosphat, fremgangsmåde til fremstilling deraf og farmaceutiske præparater indeholdende det.
DE60306503D1 (de) Statin-therapie zur verbesserung der aufrechterhaltung der kognitiven funktion
ATA57894A (de) Mittel zur behandlung von osteoporose